1. Home
  2. MSGY vs MYO Comparison

MSGY vs MYO Comparison

Compare MSGY & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSGY

Masonglory Limited Ordinary Shares

N/A

Current Price

$0.72

Market Cap

39.5M

Sector

N/A

ML Signal

N/A

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.80

Market Cap

36.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGY
MYO
Founded
2018
2004
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
36.9M
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
MSGY
MYO
Price
$0.72
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
2.2M
504.8K
Earning Date
03-13-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$23,318,482.00
$41,643,203.00
Revenue This Year
N/A
$24.07
Revenue Next Year
N/A
$17.48
P/E Ratio
$6.99
N/A
Revenue Growth
13.04
65.00
52 Week Low
$0.70
$0.71
52 Week High
$22.20
$6.39

Technical Indicators

Market Signals
Indicator
MSGY
MYO
Relative Strength Index (RSI) 31.13 37.31
Support Level $0.70 $0.76
Resistance Level $6.60 $0.85
Average True Range (ATR) 0.62 0.07
MACD -0.26 -0.01
Stochastic Oscillator 0.38 14.97

Price Performance

Historical Comparison
MSGY
MYO

About MSGY Masonglory Limited Ordinary Shares

Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: